Festival of Biologics 2026
More than a traditional CDMO—a trusted partner committed to
advancing your mRNA, viral vector, or biologics therapy from clinical
research and development through manufacturing and commercialization.
October 13–15, 2026 | Basel, Switzerland | Booth 375
About Festival of Biologics 2026
Festival of Biologics Basel is Europe’s largest biologics event, covering the drug development industry from start to finish across antibody therapies, cell and gene therapies, immunotherapies, and biosimilars. The three-day event features presentations, panels, roundtables, and workshops.
Designed for industry experts across pharma and biotech, as well as start-ups, academics, regulators, and investors, it’s a meeting place for the large-molecule therapy ecosystem, bringing together 350 world-class speakers and more than 3,000 attendees from around the globe.
Event details
Date: October 13–15, 2026
Format: In-person event
Location: Messe Basel, Hall 1
Booth number: 375
Event website: Festival of Biologics Basel 2026 | Messe Basel
Why Thermo Fisher Scientific?
Biologics development is undeniably complex, but the process doesn’t have to be chaotic.
By combining integrated CDMO and CRO services with innovative bioprocessing products and state-of-the-art manufacturing equipment, we deliver holistic, end-to-end services and solutions that support pharma and biotech drug developers on their unique journeys to market.
Connect with us at Festival of Biologics 2026 to discover a new way forward with our Accelerator™ Drug Development, Path to IND, and First-in-Human offerings. Together, we’ll explore how to advance to the next phase of biologics development—faster and more efficiently.
- Connected capabilities across every phase
- Global network of advisors to help solve what’s next
- Collaborative platform built for transparency
- Decades of experience to help reduce risk
Attend our session:
The science behind robust cell line development to produce complex biologic therapies
MAbs track: 20 minutes
Date: Tuesday, October 13
Time: 5:30–5:50 p.m.
Location: Theater 5
Speaker: Palak Patel, Manager, Technical and Scientific Affairs
The development of therapeutic biologics is being transformed by advanced technologies that accelerate timelines while enhancing productivity, quality, and scalability. This presentation at Festival of Biologics 2026 will explore how AI/ML-driven analytics, transposase-based gene integration technology, and a proven CHO-K1 cell line platform work together to enable robust cell line development and efficient process optimization.
Attendees will learn how process intensification strategies can enhance cell growth and productivity, achieving titers of up to 11 g/L while maintaining critical quality attributes. The session will also highlight how the science behind a robust cell line development platform, combined with advanced analytics and platform expertise, can accelerate the journey from cell line generation to IMPD submission and Phase I clinical trials in as little as 9 months.*
*Terms and Conditions: Titer levels provided are estimates based on third-party results and may vary depending on molecule type or other factors. Timeline from DNA to drug product and start of clinical trials may vary depending on molecule type or other factors and are estimates to be finalized after third party cell line development dates are available and confirmed. 8-month timeline will incur additional risk and is based on US based sites only. Timeline for clinical trials is dependent on clinical trials being conducted in Australia or New Zealand.
Meet our team at Festival of Biologics 2026
Visit booth 375 or schedule a 1:1 meeting to explore how we can support your biologics program—from discovery and development through IND and beyond.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon